Impact of COVID-19 Vaccines on Cerebrovascular Health
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT Number: NCT02596607
Acute stroke management represents a true medical emergency that requires prompt diagnosis and urgent treatment. However, only a small percentage of patients access to thrombolysis on time. Various actions have been implemented since 2006 in the Rhone area as part of research projects and of the 2010-2014 national stroke action plan: training of health professionals involved in the stroke management, increase of public awareness through sensibilization campaigns, implementation of telemedicine and increase of the number of hospital beds dedicated to stroke (stroke units beds).
The main objective of the STROKE 69 study is to assess the impact of these actions on intra-hospital acute stroke management times in the Rhône area. The secondary objectives are to assess the impact of these actions on the rate and place of thrombolysis, the rate of post- thrombolysis hemorrhage, the rate of thrombectomies, mortality in the acute phase, at 3 and 12 months, the level of disability at 3 and 12 months, pre-hospital times, the number of calls to SAMU centre 15 (French mobile emergency medical services, equivalent to 911) and management channels.
The investigator will perform a prospective cohort study between 06/11/2015 and 06/06/2016 and data will be compared to data collected in a previous cohorts study, the AVC-69 cohort study (Porthault Chatard et al, Int J Stroke. 2012 Oct;7(7):E13), between 06/11/2006 and 06/06/2007, before the implementation of the actions in the Rhône area.
The cohort will be constituted of all consecutive patients treated for a stroke suspicion by the Rhône SAMU centre 15, or in one of the emergency unit or stroke unit of the Rhône area, and presenting a symptom-onset (the last time the patient was seen without deficit) less than 24 hours.
After collecting data in the acute phase, patients with a confirmed diagnosis of stroke or transient ischemic attack (TIA) will be followed for 12 months after their inclusion by telephone calls at 3 and 12 months to assess the level of disability and mortality.
AVC 69 study allowed us to include 1306 patients between 2006 to 2007, the investigator plan to include at least 1300 patients in the STROKE 69 cohort with approximately 1000 confirmed strokes or TIAs.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Department of stroke unit - Hospices Civils de Lyon, Bron, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24h
Time frame: 24h
Proportion of patients thrombolysed, proportion of cerebral hemorrhage after thrombolysis, proportion of patients treated by thrombectomy
Time frame: 24h
Pre-hospital time: symptoms onset- hospital admission time (admission in stroke unit or emergency unit), time from symptom onset to call to SAMU centre 15
Time frame: 48h
Proportion of patients managed in stroke unit at acute phase
Time frame: 24h
Proportion of patients managed by fast-track (direct admission in stroke unit after call to SAMU centre 15), proportion of patients managed by the SAMU centre 15
Time frame: 24h
Proportion of patients thrombolysed in emergency unit via telemedicine / stroke unit / critical care unit )
Time frame: 12 months
Proportion of patients who died during the initial hospitalization, proportion of patients who died at 3 and 12 months, proportion of patients with disabilities at 3 and 12 months evaluated by the Modified Rankin Scale and by the Barthel Index among patients with a confirmed diagnosis of stroke or TIA
Hospices Civils de Lyon
Other
Study of the Performance of Acute Stroke Management in the Rhône Area After Implementation of a Multi-action Program
Acronym: STROKE 69
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT06317194
Brain Diseases, Cardiovascular Diseases
Berkeley, California, United States
View Trial DetailsNCT07208422
Brain Diseases, Cardiovascular Diseases
Kano, Kano State, Nigeria
View Trial DetailsNCT04042584
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial Details